Champions Oncology, Inc. Q3 FY2023 Earnings Call

Champions Oncology, Inc. (CSBR)

Earnings Call FY2023 Q3 Call date: 2023-03-15 Concluded

Quarter scorecard

Revenue

$12.77M

-3.2% YoY

Diluted EPS

$-0.18

-460% YoY

Net income

-$2.44M

-409.9% YoY

Pharmacology Services $12.12M

-4%

Product And Service Other $648,000

+18.7%

Personalized Oncology Services $6,000

-76%